{
    "patient": {
        "Name": "Richard Nguyen",
        "DateOfBirth": "1933-09-30",
        "Sex": "Male",
        "Diagnosis": "Lobular carcinoma in situ (LCIS)",
        "BodyPart": "Breast",
        "Physician": "Dr. Kimberly Jenkins",
        "TreatingInstitution": "Payne PLC"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Breast",
            "CollectedDate": "2023-07-24",
            "ReceivedDate": "2023-07-27",
            "TumorPercentage": "17%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-07-31",
            "ReceivedDate": "2023-07-31"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "PDGFRB",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.T681I Frameshift-GOF",
                "VariantAlleleFraction": "15.31%"
            },
            {
                "Gene": "XPC",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.S346P Nonsense-GOF",
                "VariantAlleleFraction": "26.74%"
            },
            {
                "Gene": "GNAS",
                "DNA Alteration": "c.680A>T",
                "GeneMutation": "p.Q227L Nonsense-GOF",
                "VariantAlleleFraction": "12.4%"
            },
            {
                "Gene": "JAK3",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.L857P Frameshift-GOF",
                "VariantAlleleFraction": "22.42%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "JAK2",
                "DNA Alteration": "c.1849G>T",
                "GeneMutation": "p.L857P Stopgain-LOF",
                "VariantAlleleFraction": "11.56%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "SIX1",
            "MSH2"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "15 m/Mb",
            "Tmbpercentile": "27%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Equivocal"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}